222 related articles for article (PubMed ID: 15569002)
1. Characterization of the inositol phosphorylceramide synthase activity from Trypanosoma cruzi.
Figueiredo JM; Dias WB; Mendonça-Previato L; Previato JO; Heise N
Biochem J; 2005 Apr; 387(Pt 2):519-29. PubMed ID: 15569002
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of yeast inositol phosphorylceramide synthase by aureobasidin A measured by a fluorometric assay.
Zhong W; Murphy DJ; Georgopapadakou NH
FEBS Lett; 1999 Dec; 463(3):241-4. PubMed ID: 10606729
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of inositol phosphorylceramide synthase by aureobasidin A in Candida and Aspergillus species.
Zhong W; Jeffries MW; Georgopapadakou NH
Antimicrob Agents Chemother; 2000 Mar; 44(3):651-3. PubMed ID: 10681333
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of Leishmania (Leishmania) amazonensis growth and infectivity by aureobasidin A.
Tanaka AK; Valero VB; Takahashi HK; Straus AH
J Antimicrob Chemother; 2007 Mar; 59(3):487-92. PubMed ID: 17242034
[TBL] [Abstract][Full Text] [Related]
5. Sphingolipid synthesis as a target for antifungal drugs. Complementation of the inositol phosphorylceramide synthase defect in a mutant strain of Saccharomyces cerevisiae by the AUR1 gene.
Nagiec MM; Nagiec EE; Baltisberger JA; Wells GB; Lester RL; Dickson RC
J Biol Chem; 1997 Apr; 272(15):9809-17. PubMed ID: 9092515
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of inositol phosphorylceramide synthase by the cyclic peptide aureobasidin A.
Aeed PA; Young CL; Nagiec MM; Elhammer AP
Antimicrob Agents Chemother; 2009 Feb; 53(2):496-504. PubMed ID: 19047657
[TBL] [Abstract][Full Text] [Related]
7. IPC synthase as a useful target for antifungal drugs.
Sugimoto Y; Sakoh H; Yamada K
Curr Drug Targets Infect Disord; 2004 Dec; 4(4):311-22. PubMed ID: 15578972
[TBL] [Abstract][Full Text] [Related]
8. The Trypanosoma brucei sphingolipid synthase, an essential enzyme and drug target.
Mina JG; Pan SY; Wansadhipathi NK; Bruce CR; Shams-Eldin H; Schwarz RT; Steel PG; Denny PW
Mol Biochem Parasitol; 2009 Nov; 168(1):16-23. PubMed ID: 19545591
[TBL] [Abstract][Full Text] [Related]
9. Proteins anchored via glycosylphosphatidylinositol and solubilizing phospholipases in Trypanosoma cruzi.
de Almeida ML; Heise N
Biol Res; 1993; 26(1-2):285-312. PubMed ID: 7670541
[TBL] [Abstract][Full Text] [Related]
10. The antifungal Aureobasidin A and an analogue are active against the protozoan parasite Toxoplasma gondii but do not inhibit sphingolipid biosynthesis.
Alqaisi AQI; Mbekeani AJ; Llorens MB; Elhammer AP; Denny PW
Parasitology; 2018 Feb; 145(2):148-155. PubMed ID: 28486997
[TBL] [Abstract][Full Text] [Related]
11. Effect of membrane perturbants on the activity and phase distribution of inositol phosphorylceramide synthase; development of a novel assay.
Aeed PA; Sperry AE; Young CL; Nagiec MM; Elhammer AP
Biochemistry; 2004 Jul; 43(26):8483-93. PubMed ID: 15222759
[TBL] [Abstract][Full Text] [Related]
12. Trypanosoma cruzi amastigote adhesion to macrophages is facilitated by the mannose receptor.
Kahn S; Wleklinski M; Aruffo A; Farr A; Coder D; Kahn M
J Exp Med; 1995 Nov; 182(5):1243-58. PubMed ID: 7595195
[TBL] [Abstract][Full Text] [Related]
13. Characteristics of inositol phosphorylceramide synthase and effects of aureobasidin A on growth and pathogenicity of Botrytis cinerea.
Wang XH; Guo XJ; Li HY; Gou P
J Gen Appl Microbiol; 2015; 61(4):108-16. PubMed ID: 26377130
[TBL] [Abstract][Full Text] [Related]
14. A novel protein phosphatase 2A (PP2A) is involved in the transformation of human protozoan parasite Trypanosoma cruzi.
González J; Cornejo A; Santos MR; Cordero EM; Gutiérrez B; Porcile P; Mortara RA; Sagua H; Da Silveira JF; Araya JE
Biochem J; 2003 Sep; 374(Pt 3):647-56. PubMed ID: 12737627
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of thiosemicarbazones and semicarbazones as potential agents anti-Trypanosoma cruzi.
Soares RO; Echevarria A; Bellieny MS; Pinho RT; de Leo RM; Seguins WS; Machado GM; Canto-Cavalheiro MM; Leon LL
Exp Parasitol; 2011 Dec; 129(4):381-7. PubMed ID: 21939658
[TBL] [Abstract][Full Text] [Related]
16. Rustmicin, a potent antifungal agent, inhibits sphingolipid synthesis at inositol phosphoceramide synthase.
Mandala SM; Thornton RA; Milligan J; Rosenbach M; Garcia-Calvo M; Bull HG; Harris G; Abruzzo GK; Flattery AM; Gill CJ; Bartizal K; Dreikorn S; Kurtz MB
J Biol Chem; 1998 Jun; 273(24):14942-9. PubMed ID: 9614099
[TBL] [Abstract][Full Text] [Related]
17. Anti-proliferative effect of the essential oil of Cymbopogon citratus (DC) Stapf (lemongrass) on intracellular amastigotes, bloodstream trypomastigotes and culture epimastigotes of Trypanosoma cruzi (Protozoa: Kinetoplastida).
Santoro GF; Cardoso MG; Guimarães LG; Freire JM; Soares MJ
Parasitology; 2007 Oct; 134(Pt 11):1649-56. PubMed ID: 17686189
[TBL] [Abstract][Full Text] [Related]
18. Disruption of the inositol phosphorylceramide synthase gene affects Trypanosoma cruzi differentiation and infection capacity.
Dos Santos NSA; Estevez-Castro CF; Macedo JP; Chame DF; Castro-Gomes T; Santos-Cardoso M; Burle-Caldas GA; Covington CN; Steel PG; Smith TK; Denny PW; Teixeira SMR
PLoS Negl Trop Dis; 2023 Sep; 17(9):e0011646. PubMed ID: 37729272
[TBL] [Abstract][Full Text] [Related]
19. Functional characterization of enzymes involved in cysteine biosynthesis and H(2)S production in Trypanosoma cruzi.
Marciano D; Santana M; Nowicki C
Mol Biochem Parasitol; 2012 Oct; 185(2):114-20. PubMed ID: 22898136
[TBL] [Abstract][Full Text] [Related]
20. Trypanosoma cruzi: in vitro activity of Epoxy-alpha-Lap, a derivative of alpha-lapachone, on trypomastigote and amastigote forms.
Bourguignon SC; Castro HC; Santos DO; Alves CR; Ferreira VF; Gama IL; Silva FC; Seguins WS; Pinho RT
Exp Parasitol; 2009 Jun; 122(2):91-6. PubMed ID: 19285074
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
